Search PubMed⌕ Search

Biomedical subjects

Y Ye

Publications and source records attributed to Y Ye.

At least 109 records · Page 6Linked to original sources

Characterization of Drosophila Presenilin and its colocalization with Notch during development.

Mutant Presenilin proteins cause early-onset familial Alzheimer's disease in humans and Caenorhabditis elegans Presenilins may facilitate Notch receptor signaling. We have isolated a Drosophila Presenilin homologue and determined the spatial and temporal distribution of the encoded protein as well as its localization relative to the fly Notch protein. In contrast to previous mRNA in situ studies, we find that Presenilin is widely expressed throughout oogenesis, embryogenesis, and imaginal development, and generally accumulates at comparable levels in neuronal and nonneuronal tissues. Double immunolabeling with Notch antibodies revealed that Presenilin and Notch are coexpressed in many tissues throughout Drosophila development and display partially overlapping subcellular localizations, supporting a possible functional link between Presenilin and Notch.

Amino Acid Sequence↗

Comparative histopathology of hepatic allografts and xenografts in the nonhuman primate.

Liver transplantation was performed in the following groups: Group 1, baboon-to-baboon allografting (n=8) (control group); Group 2, ABO-compatible vervet monkey-to-baboon xenografting (n=8); Group 3, ABO-incompatible vervet monkey-to-baboon xenografting (n=6); Group 4, pig-to-baboon xenografting (n=2); and Group 5, pig-to-rhesus monkey xenografting (n=6). Immunosuppressive therapy (cyclosporine, cyclophosphamide, and methylprednisolone) was begun 2-7 days before liver transplantation (LTx) and continued indefinitely after LTx. The liver grafts were biopsied pre-LTx and subsequently post-LTx at approximately 1 hr, 2-3 hr, 7-10 days, 20-30 days, 60 days, 120 days, and at euthanasia or spontaneous death. There were 19 successful LTxs with grafts functioning from one hour to 123 days. No pig liver (Groups 4 and 5) survived more than 5.5 hr, as there was an immediate severe vascular response after reperfusion, typical of hyperacute rejection (congestion and hemorrhage). Vascular rejection was not seen in allografts (Group 1), but early mild-to-moderate congestion and neutrophil infiltration were present in concordant xenografts (Groups 2 and 3), which were associated with moderate deposition of immunoglobulin, C3, and fibrinogen. Lymphoid cell infiltration, bile duct damage, and portal vein endothelialitis in the portal zones occurred later in both allografts (Group 1) and concordant xenografts (Groups 2 and 3), developing earlier in the presence of ABO-incompatibility (Group 3). In concordant xenografts it was usually followed by fibrosis.

Animals↗

Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis.

Marek's disease virus (MDV) induces the rapid development of overwhelming T-cell lymphomas in chickens. One of its candidate oncogenes, meq (MDV Eco Q) which encodes a bZIP protein, has been biochemically characterized as a transcription factor. Interestingly, MEQ proteins are expressed not only in the nucleoplasm but also in the coiled bodies and the nucleolus. Its novel subcellular localization suggests that MEQ may be involved in other functions beyond its transcriptional potential. In this report we show that MEQ proteins are expressed ubiquitously and abundantly in MDV tumor cell lines. Overexpression of MEQ results in transformation of a rodent fibroblast cell line, Rat-2. The criteria of transformation are based on morphological transfiguration, anchorage-independent growth, and serum-independent growth. Furthermore, MEQ is able to distend the transforming capacity of MEQ-transformed Rat-2 cells through inhibition of apoptosis. Specifically, MEQ can efficiently protect Rat-2 cells from cell death induced by multiple modes including tumor necrosis factor alpha, C2-ceramide, UV irradiation, and serum deprivation. Its antiapoptotic function requires new protein synthesis, as treatment with a protein synthesis inhibitor, cycloheximide, partially reversed MEQ's antiapoptotic effect. Coincidentally, transcriptional induction of bcl-2 and suppression of bax are also observed in MEQ-transformed Rat-2 cells. Taken together, our results suggest that MEQ antagonizes apoptosis through regulation of its downstream target genes involved in apoptotic and/or antiapoptotic pathways.

Animals↗

Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.

The intracellular domain of the prolactin (PRL) receptor (PRLr) is required for PRL-induced signaling and proliferation. To identify and test the functional stoichiometry of those PRLr motifs required for transduction and growth, chimeras consisting of the extracellular domain of either the alpha or beta subunit of human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor (GM-CSFr) and the intracellular domain of the rat PRLr were synthesized. Because the high-affinity binding of GM-CSF results from the specific pairing of one alpha- and one beta-GM-CSFr, use of GM-CSFr/PRLr chimera enabled targeted dimerization of the PRLr intracellular domain. To that end, the extracellular domains of the alpha- and beta-GM-CSFr were conjugated to one of the following mutations: (i) PRLr C-terminal truncations, termed alpha278, alpha294, alpha300, alpha322, or beta322; (ii) PRLr tyrosine replacements, termed Y309F, Y382F, or Y309+382F; or, (iii) PRLr wild-type short, intermediate, or long isoforms. These chimeras were cotransfected into the cytokine-responsive Ba/F3 line, and their expression was confirmed by ligand binding and Northern and Western blot analyses. Data from these studies revealed that heterodimeric complexes of the wild type with C-terminal truncation mutants of the PRLr intracellular domain were incapable of ligand-induced signaling or proliferation. Replacement of any single tyrosine residue (Y309F or Y382F) in the dimerized PRLr complex resulted in a moderate reduction of receptor-associated Jak2 activation and proliferation. In contrast, trans replacement of these residues (i.e., alphaY309F and betaY382F) markedly reduced ligand-driven Jak2 activation and proliferation, while cis replacement of both tyrosine residues in a single intracellular domain (i.e., alphaY309+382F) produced an inactive signaling complex. Analysis of these GM-CSFr-PRLr complexes revealed equivalent levels of Jak2 in association with the mutant receptor chains, suggesting that the tyrosine residues at 309 and 382 do not contribute to Jak association, but instead to its activation. Heterodimeric pairings of the intracellular domains from the known PRLr receptor isoforms (short-intermediate, short-long, and intermediate-long) also yielded inactive receptor complexes. These data demonstrate that the tyrosine residues at 309 and 382, as well as additional residues within the C terminus of the dimerized PRLr complex, contribute to PRL-driven signaling and proliferation. Furthermore, these findings indicate a functional requirement for the pairing of Y309 and Y382 in trans within the dimerized receptor complex.

Animals↗

[Study on certified reference material of germanium in Ganoderma lucidum].

Analytical reference material of Ge in Ganoderma lucidum is designed and prepared for accurete analysis, monitoration and evaluation in trades of farming, forestry, medicine and food hygiene for Ge. It is used in technical training, technical assessing, monitoring, data arbitrating and analytic method verifing for professional supervisors. This reference material has been certified by graphitic oven atomic absorption spectrometry, hydride spectrophotometry, polarography, chemical separation spectrophotometry, atomic fluorescence method and x-ray fluorescence method. According to Grubb's law to judge the data of each group, it is confirmed that all of seven groups certified crude data are normal distribution by checking normality D. The arithmatic mean value of all data is 0.38 microgram/g. Standard deviation is 0.08 microgram/g.

Drugs, Chinese Herbal↗

[Study of macroencapsulated islet xenografts for treatment of diabetes in mice].

The aim of this study was to prevent rejection after islet xenotransplantation. Islet obtained from Wistar Furth rats were macroencapsulated with agarose and collagen before transplanted into diabetic C57BL/6, B6AF1, and BALB/c mice. The results showed that the diabetic condition was reversed in 92.3% of recipients transplanted with macroencapsulated islets. The normoglycemic state of recipients was maintained 125.8 +/- 57.9 days without immunosuppression. The glucose tolerance curves in these mice were similar to those of normal mice. The macroencapsulated islets retrieved 103 days after transplantation showed no evidence of tissue reaction or fibrosis. These indicated that the macroencapsulated islets serve both to achieve and maintain normoglycemia of recipients, as well as to protect islet xenografts from rejection.

Animals↗

[The effect of estrogen replacement therapy on plasma nitric oxide levels in postmenopausal women].

OBJECTIVE: To investigate the effect of estrogen replacement therapy (ERT) on plasma nitric oxide (NO) levels in postmenopausal women (PMW). METHODS: The plasma concentrations of NO and serum concentrations of estradiol (E2) were assessed before and 4 weeks after placebo or ERT administration in 10 cases of healthy PMW (control group), 17 cases of healthy PMW (healthy group) and 21 cases of PMW with hyperlipidemia (hyperlipidemia group) respectively. RESULTS: There was no difference in NO concentrations between before and after placebo administration in control group. In healthy and hyperlipidemia groups, the mean concentrations of NO were significantly higher 4 weeks after ERT administration than baseline. The positive correlation between the mean percent increase of NO and the E2 concentrations after ERT administration was statistically significant in healthy group. CONCLUSION: The increase of plasma NO concentrations caused by ERT may contribute to it cardiovascular protective effect in PMW.

Estradiol↗

[Identification of interleukin-1 beta converting enzyme gene expression in human kidney].

OBJECTIVE: To confirm that Interleukin-1 beta-converting enzyme(ICE) is a first identified apoptosis related gene in mammals. METHODS: The expressions of ICE mRNA in human kidney tissue, different segment of nephron and glomerular resident cells were measured by using the method of microdissection, reverse transcription-polymerase chain reaction(RT-PCR) and Northern hybridization. RESULTS: Compared with peripheral blood mononuclear lymphocyte weak expressions of ICE mRNA were noted not only in glomeruli and tubule but also in glomerular mesangial cells, glomerular endothelial cells and tubular epithelial cells of the human kidney. CONCLUSION: There is a widely distributed expression of ICE mRNA in the human kidney, which may provide a theoretical basis for the study of ICE gene in apoptosis of kidney.

Caspase 1↗

[The deletion of AT2 receptor gene antagonizes angiotensin II-induced apoptosis in fibroblasts].

OBJECTIVE: To study the expression of angiotensin II (Ang II) type 2 receptor (AT2) and its effect on the Ang II-induced apoptosis in fibroblasts. METHODS: Skin fibroblasts were cultured from the embryos of the AT2 receptor gene deleted (AT2-/-) and wild-type (AT+/+) mice at 16 days of gestation. After Ang II being stimulated, the expressions of AT1 and AT2 receptor genes were examined by RT-PCR and the apoptotic changes were identified by genomic DNA electrophoresis, TUNEL staining and flow cytometry analysis of DNA contents. And they were compared in these two types of cultured fibroblasts. RESULTS: Treated with Ang II for 48 h at the concentrations of 10(-8), 10(-7), 10(-6) and 10(-5) mol/L respectively, the expressions of AT1 and AT2 receptor genes were enhanced in a dose-dependent manner. Induced by Ang II for 72 h at the concentrations of 10(-6) and 10(-5) mol/L, genomic DNA fragmentation, one of convinced markers of cell apoptosis was found in the AT2+/+ fibroblasts, but not in the AT2-/- fibroblasts. The percentages of Ang-induced apoptosis of the AT2+/+ fibroblasts were (12.3 +/- 2.7)% (10(-6) mol/L) and (21.7 +/- 6.7)% (10(-5) mol/L) respectively. CONCLUSION: The Ang II-induced apoptosis of fibroblasts was devoid after deletion of AT2 receptor gene.

Angiotensin II↗

[Angiotensin II type 2 receptor inhibits type 1 receptor-induced cell proliferation and fibronectin release in mouse fibroblasts].

OBJECTIVE: To investigate the effects of angiotensin II type 2 receptor (AT2) on the cell proliferation and fibronectin release induced by angiotensin II type 1 receptor (AT1). METHOD: Fibroblats were cultured from embryonic skin of AT2 receptor gene knocked-out mice (AT2-/-) and wild-type mice (AT2+/+) after 16 days of gestation, respectively. Cell proliferation and fibronectin release were examined in the fibroblasts treated with 10(-8) mol/L angiotensin II. RESULTS: Cell proliferation rate was increased more markedly in the AT2-/- fibroblasts than in the AT2+/+ fibroblasts after treament with angiotensin II (0.462 +/- 0.026 VS 0.389 +/- 0.021, P < 0.01). Also, fibronectin release and its gene expression were significantly enhanced in the AT2-/- fibroblasts as compared with the AT2+/+ fibroblasts when exposed to angiotensin II (34.1 +/- 4.1)% vs (16.2 +/- 2.3)%, P < 0.01). CONCLUSION: The AT2 receptor can inhibit the cell proliferation and fibronectin release induced by the AT1 receptor.

Angiotensin II↗

[Influence of compensatory hepatocyte proliferation on the carcinogenesis of N-nitrosodimethylamine].

OBJECTIVE: To study the influence of compensatory hepatocyte proliferation on the N-nitrosodimethylamine (NDMA) carcinogenesis in rats. METHODS: NDMA was given to animals of the experimental group 24 hours after partial hepatectomy, and the control group was only treated with NDMA. Expression of gamma-glutamyltransferase (GGT), glutathione S-transferase placental form (GSTP), proliferating cell nuclear antigen (PCNA), insulin-like growth factor-II (IGF-II) and oncogenes was detected. RESULTS: The numbers and areas of GGT- and GSTP-foci in the experimental group were significantly increased in comparing with the control groups. The expression of GSTP was higher than that of GGT. The total tumor incidence of the experimental group was higher than that of the control by the end of the 56th week. Up to week 71, the incidences of liver and other tumors were higher respectively in the experimental group. The amount of PCNA positive cells were corresponding with proliferative condition of the hepatic lesions. The expression of IGF-II, c-myc and H-ras mRNA increased in the altered hepatocyte foci and nodules, but markedly decreased in hepatocellular carcinoma and adenoma. No c-jun mRNA expression was detected in all the normal and abnormal tissues of liver. CONCLUSIONS: The results suggest that compensatory hepatocyte proliferation enhances the carcinogenesis induced by multiple doses of NDMA, and the over expression of IGF-II, c-myc, H-ras may play a synergetic role in NDMA-induced hepatocarcinogenesis.

Animals↗

[The relationship between nm23-H1 loss of heterozygosity and metastasis in hepatocellular carcinoma].

OBJECTIVE: To demonstrate the relationship between nm23-H1 loss of heterozygosity (LOH) and clinical pathological characteristics of hepatocellular carcinoma (HCC) from the DNA level. METHOD: Southern blot hybridization was used to analyze genomic DNA in liver cancer and its corresponding liver tissue. RESULT: nm23-H1 has diallelic bands at 7.6 Kb and 2.3 Kb. Allelic loss of heterozygosity in tumour tissues was detected in 31.25% patients (5 patients). LOHs were more common in the tumours with intrahepatic metastasis or portal vein tumour embolism and the tumours poorly differentiated (Edmondson's classification III, IV). CONCLUSION: nm23-H1 LOHs may induce the metastasis potential of HCC and help to predict recurrence and metastasis of HCC.

Carcinoma, Hepatocellular↗

[Studies on the anticancer effect of howiinol A, a new compound isolated from Goniothalamus howii].

The effect of howiinol A (GHM-10) on the growth of several cancer and normal cells were studied, using the methods of cell growth curve determination, MTT test and soft-agar colony formation assay. The results showed that GHM-10 exhibited potent inhibitory effect on cancer cells with an IC50 of 2 micrograms.ml-1 approximately. Normal cells, especially bone marrow progenitor cells, were shown to be less sensitive to GHM-10. A drug-resistant cell line, KB/VCR200, was found to be as sensitive as its parental KB cells. GHM-10 did not induce HL-60 cell differentiation. In murine transplantable tumors, GHM-10 was found to have significant therapeutic effect on mice bearing solid tumor hepatoma H22, Lewis lung carcinoma and S180 ascites.

Animals↗

[Antitumor activity of howiinol (GHM-10) on L1210 cells in vitro].

Howiinol(GHM-10) is a new compound isolated from Goniothalamus howii. Previous studies showed that GHM-10 significantly inhibited the growth of cancer cells both in vitro and in vivo. In the present study, the characteristics of the inhibitory effect of GHM-10 on L1210 cells was investigated. The results showed that the IC50 of L1210 cells treated with GHM-10 for 1 h, 24 h, and 7 d was 6.85, 3.32 and 1.59 micrograms.ml-1, respectively. This outcome is in compliance with the hypothesis that GHM-10 is a cell cycle non-specific cytotoxic drug. When L1210 cells were treated with 1-2 micrograms.ml-1 of GHM-10 for 24 h, the growth rate and mitotic index were decreased and the morphology of cell nuclei changed, but the cell viability remained at the level of 96% or more, indicating that GHM-10 mainly inhibited cell proliferation. The cell cycle kinetics of L1210 cells were studied by using a flow cytometer. The results showed that the transition of cells from G1 phase to S phase was blocked to certain extent by the treatment of GHM-10 4 micrograms.ml-1 for 12 h. The fluidity of cell membrane was also increased when the L1210 cells were exposed to 2-3 micrograms.ml-1 of GHM-10 for 24 h.

Animals↗

Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.

BACKGROUND: This study sought to (i) investigate the efficacy of cobra venom factor (CVF) in preventing hyperacute rejection (HAR) after pig-to-baboon heart transplantation, (ii) examine the effect of additional splenectomy (Spx) and pharmacologic immunosuppression (IS), and (iii) study delayed graft rejection when HAR is avoided by complement depletion. METHODS: Eleven recipient baboons received heterotopic pig heart transplants. Three received either no therapy or IS (cyclosporine + methylprednisolone +/- cyclophosphamide +/- methotrexate) at clinically well-tolerated doses, with graft survival for only 40, 32, and 15 min, respectively. Two received CVF+/-Spx, which extended survival to 5 and 6 days, respectively. Six underwent Spx + CVF therapy + IS; graft survival was 3 hr (technical complication), 6 days (death from sepsis), 10, 12, and 22 days (vascular rejection), and <25 days (euthanized for viral pneumonia with a functioning graft that showed histopathologic features of vascular rejection). RESULTS: Dense deposition of IgM and, to a lesser extent, IgG and IgA were seen on the endothelial cells within 1 hr of transplantation, but only trace levels of complement deposition were present in CVF-treated recipients. Within approximately 5-12 days, cardiac xenografts showed progressive infiltration by mononuclear cells, consisting primarily of activated macrophages producing tumor necrosis factor-alpha and small numbers of natural killer cells; T and B cells were absent. CONCLUSIONS: We conclude that (i) CVF prevents HAR, (ii) the addition of Spx + IS delays rejection, but (iii) the early deposition of antibody leads to progressive graft injury, resulting in (iv) delayed vascular rejection. Our findings indicate that the features of delayed xenograft rejection described in small animal models also occur in the pig-to-baboon model, and that rejection may occur in a complement-independent manner from the effects of antibody and/or host macrophages.

Acute Disease↗

Ultrastructure changes associated with brain death in the human donor heart.

Electromicroscopic examinations were carried out on 30 myocardial biopsies taken from 22 human donor hearts immediately after excision (prestorage) or immediately before transplantation (poststorage). All electron micrographs were independently examined by two morphologists. Eleven structures were examined in each micrograph, and each structure was scored according to the degree of injury. A good interobserver correlation was obtained in 84% of the structures scored. In the prestorage left ventricular biopsies (n = 11), approximately 20%-25% showed moderate to severe ultrastructural injury. The ultrastructural injury observed in the poststorage left ventricular biopsies (n = 15) was no different from that in the prestorage group, particularly injury to the sarcomere and mitochondria. A similar degree and pattern of injury was seen in the right ventricle (n = 4). There was no evidence that an ischemic storage period of less than 6 h increased the degree of injury seen. However, there was a higher incidence of moderate to severe injury in those hearts excised from donors initially dependent on high inotropic support.

Adolescent↗